Neutralizing antibodies in hepatitis C virus infection: A review of immunological and clinical characteristics

Mitchell Kaplan, Samer Gawrieh, Scott J. Cotler, Donald M. Jensen

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Hepatitis C infection induces cross-reactive neutralizing antibodies that, in some cases, prevent primary infection in animal models. Neutralizing antibodies target the HVR1 of the E2 glycoprotein, and a conserved region at the C-terminus of HVR1 determines cross-reactivity. The humoral immune response appears to be the driving force leading to variability in HVR1, resulting in emergence of escape mutants and persistence of HCV infection. Advances in understanding the humoral response to HCV could facilitate development of a vaccine for hepatitis C as well as an effective HCIG preparation containing cross-reactive neutralizing antibodies to HCV.

Original languageEnglish (US)
Pages (from-to)597-604
Number of pages8
JournalGastroenterology
Volume125
Issue number2
DOIs
StatePublished - Aug 1 2003
Externally publishedYes

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Neutralizing antibodies in hepatitis C virus infection: A review of immunological and clinical characteristics'. Together they form a unique fingerprint.

  • Cite this